Two‐stage penalized regression screening to detect biomarker–treatment interactions in randomized clinical trials
From MaRDI portal
Publication:6055537
DOI10.1111/biom.13424zbMath1520.62357arXiv2004.12028OpenAlexW3124934600MaRDI QIDQ6055537
Unnamed Author, Ashish Patel, James M. S. Wason, Unnamed Author
Publication date: 30 October 2023
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/2004.12028
Related Items (1)
Cites Work
- Unnamed Item
- Unnamed Item
- Augmented case-only designs for randomized clinical trials with failure time endpoints
- Testing for gene-environment interaction under exposure misspecification
- Two-stage testing procedures with independent filtering for genome-wide gene-environment interaction
- Multiple Comparisons Among Means
- Exploiting Gene‐Environment Independence for Analysis of Case–Control Studies: An Empirical Bayes‐Type Shrinkage Estimator to Trade‐Off between Bias and Efficiency
- Semiparametric Estimation Exploiting Covariate Independence in Two‐Phase Randomized Trials
- Asymptotic Statistics
- Sure Independence Screening for Ultrahigh Dimensional Feature Space
- High Dimensional Ordinary Least Squares Projection for Screening Variables
- Rectangular Confidence Regions for the Means of Multivariate Normal Distributions
This page was built for publication: Two‐stage penalized regression screening to detect biomarker–treatment interactions in randomized clinical trials